Ipilimumab vs Tramadol
Ipilimumab vs Tramadol: Overview
This comparison examines the pharmacological differences between Ipilimumab and Tramadol.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Tramadol: Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Tramadol — 5-7 hours.
Chemical Properties
Molecular Formula: Tramadol — C16H25NO2.
Molecular Weight: Tramadol — 263.3750 g/mol.
Type: Ipilimumab — Antibody; Tramadol — Small molecule.